SCHEMBL15032

SCHEMBL15032

CCCC([O])CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL580950 0.85
SCHEMBL497218 0.80
SCHEMBL277133 0.78
SCHEMBL22505 0.76
SCHEMBL2879718 0.76
SCHEMBL28047406 0.76
SCHEMBL1130574 0.76
SCHEMBL2882491 0.76
SCHEMBL6436033 0.76 LCK (0.48)
SCHEMBL6435933 0.76 LCK (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10834 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118354999-A Pyridazine-1 (6H) -6-oxo compound and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-07-16 CN claimed
CN-115960039-B Aromatic ring substituted pyridine quaternary ammonium salt derivative and preparation method and application thereof 山东大学 2024-07-12 CN claimed
WO-2024120457-A1 PYRROLO[3,2-D]PYRIMIDIN-4-ONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 深圳信立泰药业股份有限公司 2024-06-13 WO claimed
CN-118126046-A Substituted macrocyclic compound, and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-06-04 CN claimed
US-20240166627-A1 Terpyridinedione compound or salt thereof, and preparation method and application thereof SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) 2024-05-23 US claimed
CN-117586284-A Macrocyclic compound, and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-02-23 CN claimed
WO-2023246677-A1 INDOLE-PHENYLPIPERIDINE COMPOUND, METHOD FOR PREPARING SAME, AND USE THEREOF 深圳信立泰药业股份有限公司 2023-12-28 WO claimed
CN-116648244-B Terpyridyl dione compound or salt thereof, and preparation method and application thereof 深圳信立泰药业股份有限公司 2023-12-15 CN claimed
CN-117100752-A Medical use of glucagon-like peptide-1 (GLP-1) receptor agonists 深圳信立泰药业股份有限公司 2023-11-24 CN claimed
WO-2023213745-A1 PROCESS FOR PREPARING A POLYCARBONATE BY METAL CATALYZED CROSS COUPLING COVESTRO DEUTSCHLAND AG (DE) 2023-11-09 WO claimed
US-20090185867-A1 MARINE ANTI-FOULANT SYSTEM AND METHODS FOR USING SAME ASSET INTEGRITY MANAGEMENT SOLUTIONS, L.L.C., D/B/A AIMS INTERNATIONAL 2009-07-23 US claimed
CN-1247551-C Non-yellowing ortho-dialkylaryl substituted triazine ultraviolet light absorbers CYTEC TECH CORP (US) 2006-03-29 CN claimed
CN-1678618-A Process for separating and deprotecting oligonucleotides QUIATECH AB (SE) 2005-10-05 CN claimed
EP-1569925-A1 2-SUBSTITUTED QUINAZOLIN-4-YLAMINE ANALOGUES AS CAPSAICIN RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2005-09-07 EP claimed
WO-2004055003-A1 2-SUBSTITUTED QUINAZOLIN-4-YLAMINE ANALOGUES AS CAPSAICIN RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2004-07-01 WO claimed
CN-1478083-A Non-yellowing ortho-dialkylaryl substituted triazine ultraviolet light absorbers CYTEC 2004-02-25 CN claimed
US-20020193560-A1 CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY ASTELLAS PHARMA INC. (JP) 2002-12-19 US claimed
CN-1268056-A Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases UNIV NORTH CAROLINA (US) 2000-09-27 CN claimed
EP-0941236-A1 CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-09-15 EP claimed
WO-1998023637-A1 CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-04 WO claimed